Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than expected have ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to ...

Omalizumab works by binding to the allergy-causing antibody called immunoglobulin E in the blood and preventing it from ...

The study of success eating food triggers after stopping Xolair is ongoing, so researchers are still collecting data for doctors to use making treatment plans with their patients. Parents interested ...

A new clinical trial reveals that the asthma drug omalizumab (Xolair) helps food-allergic children eat trigger foods safely.

Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to resul ...

Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...

A new study has revealed that the injectable asthma drug helped more than one-third of the kids to overcome their food ...

Pharvaris (PHVS) highlighted safety and efficacy data of deucrictibant, which is currently being evaluated in two pivotal Phase 3 studies, ...

Infants who did not exclusively feed on colostrum during their first 3 days of life were more likely to develop egg or peanut ...